Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: Diagnostic implications and pitfalls

American Journal of Surgical Pathology

Volumn 35, Issue 6, 2011, Pages 787-798

  Paner, Gladell P ^a   McKenney, Jesse K ^b   Barkan, Güliz A ^c   Yao, Jorge L ^d   Frankel, Wendy L ^e   Sebo, Thomas J ^f   Shen, Steven S ^g   Jimenez, Rafael E ^f  

^a UNIVERSITY OF CHICAGO   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f HOUSTON METHODIST HOSPITAL   (United States)

^g MAYO CLINIC   (United States)

Author keywords

catenin; adenocarcinoma; carcinoma; CDX2; claudin 18; immunohistochemistry; Reg IV; urachal

Indexed keywords

CDX2 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; TUMOR MARKER;

ADENOCARCINOMA; ARTICLE; BLADDER TUMOR; COLON TUMOR; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; TISSUE MICROARRAY;

ADENOCARCINOMA; COLONIC NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 79957992674     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182189c11     Document Type: Article

References (71)

1. Ashley RA, Inman BA, Sebo TJ, et al. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer. 2006;15:712-720. (Pubitemid 44232663)
2. Ayala AG, Tamboli P. Urachal carcinoma. In: Eble JN, Sauter G, Epstein JI, et al, eds. World Health Organization Classification of Tumours. Albany, NY: WHO Publications Center; 2004:131-132.
3. Barbareschi M, Murer B, Colby TV, et al. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol. 2003;27:141-149. (Pubitemid 36152222)
4. Barth AI, Nä thke IS, Nelson WJ. Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol. 1997;9:683-690. (Pubitemid 27424925)
5. Bates AW, Baithun SI. Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases. Histopathology. 2000;36:32-40. (Pubitemid 30055420)
6. Bismar TA, Humphrey PA, Grignon DJ, et al. Expression of betacatenin in prostatic adenocarcinomas: a comparison with colorectal adenocarcinomas. Am J Clin Pathol. 2004;121:557-563. (Pubitemid 38392964)
7. Burnett AL, Epstein JI, Marshall FF. Adenocarcinoma of urinary bladder: classification and management. Urology. 1991;37:315-321.
8. Carr NJ, McLean AD. A mucinous tumour of the urachus: adenoma or low grade mucinous cystic tumour of uncertain malignant potential? Adv Clin Path. 2001;5:93-97.
9. Cheng L, Montironi R, Bostwick DG. Villous adenoma of the urinary tract: a report of 23 cases, including 8 with coexistent adenocarcinoma. Am J Surg Pathol. 1999;23:764-771. (Pubitemid 29307681)
10. Choi WWL, Amin MB, Tamboli P, et al. Glandular neoplasms of the urachus: clinicopathologic and immunohistochemical analysis of 43 cases with special emphasis on low-grade mucinous cystic tumors. Mod Pathol. 2005;18:134A.
11. Chu PG, Weiss LM. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol. 2004;121:884-892. (Pubitemid 38669284)
12. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13:962-972.
13. De Lott LB, Morrison C, Suster S, et al. CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites. Arch Pathol Lab Med. 2005;129: 1100-1105. (Pubitemid 41242420)
14. Dennis JL, Hvidsten TR, Wit EC, et al. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res. 2005;11:3766-3772. (Pubitemid 40685594)
15. Eble JN, Hull MT, Rowland RG, et al. Villous adenoma of the urachus with mucusuria: a light and electron microscopic study. J Urol. 1986;135:1240-1244. (Pubitemid 16095882)
16. Egevad L, Ha? kansson U, Grabe M, et al. Urachal signet-cell adenocarcinoma. Scand J Urol Nephrol. 2009;43:88-91.
17. El-Ghobashy A, Ohadike C, Wilkinson N, et al. Recurrent urachal mucinous adenocarcinoma presenting as bilateral ovarian tumors on cesarean delivery. Int J Gynecol Cancer. 2009;19:1539-1541.
18. Gonzalez E, Fowler MR, Venable DD. Primary signet ring cell adenocarcinoma of the bladder (linitis plastica of the bladder): report of a case and review of the literature. J Urol. 1982;128: 1027-1030. (Pubitemid 13211662)
19. Gopalan A, Sharp DS, Fine SW, et al. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation. Am J Surg Pathol. 2009;33:659-668.
20. Grignon DJ, Ro JY, Ayala AG, et al. Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases. Cancer. 1991;67:2165-2172.
21. Grignon DJ, Ro JY, Ayala AG, et al. Primary signet-ring cell carcinoma of the urinary bladder. Am J Clin Pathol. 1991;95:13-20.
22. Herr HW, Bochner BH, Sharp D, et al. Urachal carcinoma: contemporary surgical outcomes. J Urol. 2007;178:74-78. (Pubitemid 46898469)
23. Hull MT, Warfel KA. Urachal cystadenoma with abundant glycogen: ultrastructural study. Ultrastruct Pathol. 1994;18:499-502. (Pubitemid 24296126)
24. Irwin PP, Weston PM, Sheridan W, et al. Transitional cell carcinoma arising in a urachal cyst. Br J Urol. 1991;67:103-104.
25. James R, Erler T, Kazenwadel J. Structure of the murine homeobox gene cdx-2. Expression in embryonic and adult intestinal epithelium. J Biol Chem. 1994;269:15229-15237.
26. Johansson SL, Borghede G, Holmäng S. Micropapillary bladder carcinoma: a clinicopathological study of 20 cases. J Urol. 1999;161: 1798-1802. (Pubitemid 29420734)
27. Johnson DE, Hodge GB, Abdul-Karim FW, et al. Urachal carcinoma. Urology. 1985;26:218-221. (Pubitemid 17045594)
28. Karanjawala ZE, Illei PB, Ashfaq R, et al. New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8. Am J Surg Pathol. 2008;32: 188-196. (Pubitemid 351172132)
29. Kobayashi M, Honma T, Matsuda Y, et al. Nuclear translocation of beta-catenin in colorectal cancer. Br J Cancer. 2000;82:1689-1693. (Pubitemid 30229580)
30. Kuramoto T, Kikkawa K, Nishihata M, et al. Squamous cell carcinoma of the urachus producing granulocyte colony-stimulating factor. Urology. 2009;73:442.
31. Lane Z, Hansel DE, Epstein JI. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder. Am J Surg Pathol. 2008;32:1322-1326.
32. Logani S, Oliva E, Arnell PM, et al. Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma. Mod Pathol. 2005;18:19-25. (Pubitemid 40128090)
33. Mart́nez A, Ferron G, Mery E, et al. Peritoneal pseudomyxoma arising from the urachus. Surg Oncol. 2010 [Epub ahead of print].
34. Matsuda M, Sentani K, Noguchi T, et al. Immunohistochemical analysis of colorectal cancer with gastric phenotype: claudin-18 is associated with poor prognosis. Pathol Int. 2010;60:673-680.
35. McKenney JK. Urachal adenocarcinoma. In: Amin MB,McKenney JK, Tickoo SK, et al, eds. Diagnostic Pathology Genitourinary. Salt Lake City, UT: Amirsys Publishing, Inc.; 2010:142-147.
36. McKenney JK, Amin MB. The role of immunohistochemistry in the diagnosis of urinary bladder neoplasms. Semin Diagn Pathol. 2005;22:69-87. (Pubitemid 43163180)
37. McMahon RF, Hunt CR. In situ adenocarcinoma of the bladder: the role of the urachus. Am J Surg Pathol. 2002;26:271-272. (Pubitemid 34127510)
38. Merchant SH, Amin MB, Tamboli P, et al. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas. Am J Surg Pathol. 2001;25:1515-1519. (Pubitemid 33096966)
39. Misdraji J, Yantiss RK, Graeme-Cook FM, et al. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol. 2003;27:1089-1103. (Pubitemid 36909530)
40. Molina JR, Quevedo JF, Furth AF, et al. Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases. Cancer. 2007;110:2434-2440. (Pubitemid 350174928)
41. Moskaluk CA, Zhang H, Powell SM, et al. Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod Pathol. 2003;16:913-919. (Pubitemid 37152021)
42. Ohira S, Shiohara S, Itoh K, et al. Urachal adenocarcinoma metastatic to the ovaries: case report and literature review. Int J Gynecol Pathol. 2003;22:189-193. (Pubitemid 36348795)
43. Ortiz-Rey JA, Antó n Badiola I, San Miguel Fraile P, et al. Expression of CDX2 in urinary bladder and urethra lesions. Actas Urol Esp. 2004;28:101-105.
44. Oue N, Mitani Y, Aung PP, et al. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J Pathol. 2005;207:185-198. (Pubitemid 41404149)
45. Oue N, Kuniyasu H, Noguchi T, et al. Serum concentration of Reg IV in patients with colorectal cancer: overexpression and high serum levels of Reg IV are associated with liver metastasis. Oncology. 2007;72:371-380. (Pubitemid 351238152)
46. Paner GP, Sebo TJ, Jimenez RE. Non-glandular carcinomas of the urachus. Mod Pathol. 2010;23:210A.
47. Pantuck AJ, Bancila E, Das KM, et al. Adenocarcinoma of the urachus and bladder expresses a unique colonic epithelial epitope: an immunohistochemical study. J Urol. 1997;158:1722-1727. (Pubitemid 27433140)
48. Qualtrough D, Hinoi T, Fearon E, et al. Expression of CDX2 in normal and neoplastic human colon tissue and during differentiation of an in vitro model system. Gut. 2002;51:184-190. (Pubitemid 34791444)
49. Raspollini MR, Nesi G, Baroni G, et al. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder. Appl Immunohistochem Mol Morphol. 2005;13:358-362. (Pubitemid 41697399)
50. Rubin JP, Kasznica JM, Davis CA III, et al. Transitional cell carcinoma in a urachal cyst. J Urol. 1999;162:1687-1688. (Pubitemid 29474695)
51. Sanada Y, Oue N, Mitani Y, et al. Down-regulation of the claudin- 18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J Pathol. 2006;208:633-642.
52. Santucci RA, True LD, Lange PH. Is partial cystectomy the treatment of choice for mucinous adenocarcinoma of the urachus? Urology. 1997;49:536-540. (Pubitemid 27161411)
53. Schell AJ, Nickel CJ, Isotalo PA. Complex mucinous cystadenoma of undetermined malignant potential of the urachus. Can Urol Assoc J. 2009;3:E39-E41.
54. Seibel JL, Prasad S, Weiss RE, et al. Villous adenoma of the urinary tract: a lesion frequently associated with malignancy. Hum Pathol. 2002;33:236-241. (Pubitemid 34298741)
55. Sentani K, Oue N, Tashiro T, et al. Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma. Am J Surg Pathol. 2008; 32:1182-1189.
56. Sheldon CA, Clayman RV, Gonzalez R, et al. Malignant urachal lesions. J Urol. 1984;131:1-8. (Pubitemid 14218075)
57. Siefker-Radtke AO, Gee J, Shen Y, et al. Multimodality management of urachal carcinoma: the MD Anderson Cancer Center experience. J Urol. 2003;169:1295-1298. (Pubitemid 36323770)
58. Suh N, Yang XJ, Tretiakova MS, et al. Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Mod Pathol. 2005;18: 1217-1222. (Pubitemid 43079921)
59. Sullivan LM, Smolkin ME, Frierson HF Jr, et al. Comprehensive evaluation of CDX2 in invasive cervical adenocarcinomas: immunopositivity in the absence of overt colorectal morphology. Am J Surg Pathol. 2008;32:1608-1612.
60. Sung MT, Lopez-Beltran A, Eble JN, et al. Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder. Mod Pathol. 2006;19:1395-1401. (Pubitemid 44624156)
61. Tamboli P, Mohsin SK, Hailemariam S, et al. Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel. Arch Pathol Lab Med. 2002;126:1057-1063. (Pubitemid 36221843)
62. Tamura H, Ohtsuka M, Washiro M, et al. Reg IV expression and clinicopathologic features of gallbladder carcinoma. Hum Pathol. 2009;40:1686-1692.
63. Thomas AA, Stephenson AJ, Campbell SC, et al. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder. Hum Pathol. 2009;40:108-116.
64. Torenbeek R, Lagendijk JH, Van Diest PJ, et al. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma. Histopathology. 1998;32:20-27.
65. Tot T. Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer. 2002;38:758-763. (Pubitemid 34280319)
66. Tran B, McKendrick J. Metastatic urachal cancer responding to FOLFOX chemotherapy. Can J Urol. 2010;17:5120-5123.
67. Wang HL, Lu DW, Yerian LM, et al. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol. 2001;25: 1380-1387. (Pubitemid 33022053)
68. Wasco MJ, Daignault S, Zhang Y, et al. Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. Urology. 2007;70:69-74. (Pubitemid 47081105)
69. Werling RW, Yaziji H, Bacchi CE, et al. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27:303-310. (Pubitemid 36245795)
70. Williamson SR, Lopez-Beltran A, Montironi R, et al. Glandular lesions of the urinary bladder: clinical significance and differential diagnosis. Histopathol. Doi: 10.1111/j.1365-2559.2010.03651.x.
71. Young RH, Eble JN. Unusual forms of carcinoma of the urinary bladder. Hum Pathol. 1991;22:948-965.